Azelastine Hydrochloride/Fluticasone Propionate

Tier C — Watch / trade

Mylan Nv

Originator

2012

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：HRH1, GR, PLA2G4A

Brand：Dymista

Indications (approved)：Allergic rhinitis, Seasonal allergic rhinitis

Regional status

Approved

2012-05-01

No progress

2010-08-01

China

Approved

2022-11-01

Japan

Factories producing this API11

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

11 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Azelastine Hydrochloride/Fluticasone Propionate?

Approved indications include: Allergic rhinitis, Seasonal allergic rhinitis.

When does the Azelastine Hydrochloride/Fluticasone Propionate patent expire?

No public expiry year is available for Azelastine Hydrochloride/Fluticasone Propionate yet; this page updates once verified.

How do I get a quote for Azelastine Hydrochloride/Fluticasone Propionate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27